Received: from JNET-Daemon by UNCVX1.BITNET; Thu, 7 Feb 91 08:30 EDT
Received: From UNC(MAILER) by UNCVAX1 with Jnet id 0032 for PJONES@UNCVAX1;
 Thu,  7 Feb 91 08:29 EST
Date: Thu, 07 Feb 91 08:30 EST
From: Dot Baker <UNCDOT@UNC.BITNET>
Subject: NIH Guide Part 2  February 8, l99l
To: pjones@UNCVX1.BITNET

Hello,
   Two of six.   Please post this to the NIH Listserver as:
NIHGUIDE2.910208
                Dottie
 ---------------------------- Text of forwarded message -----------------------
 
X-comment: NIH Guide (including TOC) contained 22 pages (1760 lines)
X-comment: RFAs described:  AI-91-03, CA-91-04, AI-91-02, DK-NR-91-09
 
The usual NIH policies concerning research on human subjects also apply.
Basic research or clinical studies in which human tissues cannot be identified
or linked to individuals are excluded.  However, every effort should be made
to include human tissues from women and racial/ethnic minorities when it is
important to apply the results of the study broadly, and this should be
addressed by applicants.
 
For foreign awards, the policy on inclusion of women applies fully; since the
definition of minority differs in other countries, the applicant must discuss
the relevance of research involving foreign population groups to the United
States' populations, including minorities.
 
If the required information is not contained within the application, the
application will be returned.
 
Peer reviewers will address specifically whether the research plan in the
application conforms to these policies.  If the representation of women or
minorities in a study design is inadequate to answer the scientific
 
            NIH GUIDE - Vol. 20, No. 6, February 8, 1991 - Page 18
question(s) addressed AND the justification for the selected study population
is inadequate, it will be considered a scientific weakness or deficiency in
the study design and will be reflected in assigning the priority score to the
application.
 
All applications for clinical research submitted to NIH are required to
address these policies.  NIH funding components will not award grants or
cooperative agreements that do not comply with these policies.
 
MECHANISMS OF SUPPORT
 
Applications in any of the NIDDK mechanisms of support are accepted.
Especially encouraged are the Research Project Grant (R01), First Independent
Research Support and Transition Award (R29), National Research Service Award
(NRSA) (F32), and Clinical Investigator Award (K08).
 
APPLICATION PROCEDURES
 
Applicants must use the standard research grant application form PHS 398
(revised 10/88) or the appropriate fellowship application forms PHS 416-1
(revised 7/88 or 4/89).  These forms are available from the Office of
Sponsored Research at most institutions and from the Division of Research
Grants, National Institutes of Healthi, Westwood Building, Room 449, Bethesda,
MD 2082.
 
Receipt dates for the applications are listed on the forms.  For new research
projects (R01 and R29) the dates are February 1, June 1, and October 1 and for
Clinical Investigator Award applications.  Receipt dates for NRSA fellowship
applications are January 10, May 10, and September 10.
 
To identify responses to this announcement, check "yes" and list the title and
number of this announcement in item number 2 on the face page of the
application form.  Use the mailing label provided in the application kit and
mail the signed original and six copies to:
 
Division of Research Grants
National Institutes of Health
Westwood Building, Room 240
Bethesda, MD  20892**
 
Applications will be reviewed for scientific and technical merit by
appropriate study sections comprised primarily of non-federal experts.
Secondary review will be performed by the appropriate National Advisory
Council.
 
Potential applicants are strongly advised to call or write for further
information:
 
Ralph L. Bain, Ph.D.
Acting Director, Urology Program
DKUHD/NIDDK
National Institutes of Health
Federal Building, Room 102
Bethesda, MD  20892
Telephone:  (301) 496-8248
 
or
 
Joan T. Harmon, Ph.D.
Executive Director, Diabetes Research Program, DPB
DDEMD, NIDDK
National Institutes of Health
Westwood Building, Room 622
Bethesda, MD  20892
Telephone:  (301) 496-7731
 
These programs are described in the Catalog of Federal Domestic Assistance
Nos. 93.849, 93.847.  Awards will be made under the authority of the Public
Health Service Act, Section 301 (42 USC 241) and administered under PHS grant
policies and Federal Regulations 42 CFR Part 52 and 45 CFR Part 74.  This
program is not subject to Health Systems Agency review.
 
 
 
 
 
 
 
 
            NIH GUIDE - Vol. 20, No. 6, February 8, 1991 - Page 19
                              NOTICE OF MEETING
 
 
NATIONAL WORKSHOPS ON "PROTECTION OF HUMAN SUBJECTS"
 
P.T. 42; K.W. 0783005
 
National Institutes of Health
Food and Drug Administration
 
The National Institutes of Health (NIH) and the Food and Drug Administration
(FDA) are continuing to sponsor a series of workshops on the responsibilities
of researchers, Institutional Review Boards (IRBs), and institutional
officials for the protection of human subjects in research.  The workshops are
open to everyone with an interest in research involving human subjects.  The
meetings should be of special interest to those persons currently serving or
about to begin serving as a member of an IRB.  Issues discussed at these
workshops are relevant to all other Public Health Service agencies.  The
current schedule includes the following:
 
I.  MIDEAST WORKSHOP
 
DATES:  March 4-5, 1991
 
WORKSHOP SITE:
Friday Center
Laurel Hill Parkway
Chapel Hill, NC  27599-1020
 
SPONSORS:
University of North Carolina at Chapel Hill
300 Bynum Hall
Chapel Hill, NC  27599-4100
 
Shaw University
118 E. South Street
Raleigh, NC  27611
 
REGISTRATION CONTACT:
Mr. Al Dawson
Director
Friday Center
Laurel Hill Parkway
C. B. 1020
Chapel Hill, NC  27599-1020
Telephone:  (919) 962-1106
 
TOPIC:  "Interpreting the Federal Code for the Protection of Human Subjects"
 
II.  MIDWEST WORKSHOP
 
DATES:  April 11-12, 1991
 
WORKSHOP SITE:
Ramada Inn, Lakeshore
4900 South Lake Shore Drive
Chicago, IL  60615
 
SPONSORS:
University of Chicago
970 East 58th Street
Chicago, IL  60637
 
Chicago State University
95th Street at King Drive
Chicago, IL  60628
 
REGISTRATION CONTACT:
Mr. Arnold L. Aronoff
Associate Director
Faculty and Administrative Services
University Research Administration
University of Chicago
970 East 58th Street
Chicago, IL  60637
Telephone:  (312) 702-8669
 
 
 
            NIH GUIDE - Vol. 20, No. 6, February 8, 1991 - Page 20
TOPIC:  "Cultural Diversity, Ethics, and Research:  A Workshop on Human
Subject Protection"
 
NIH/FDA have planned national human subject protections workshops in other
parts of the United States.  For further information regarding these workshops
contact:
 
Darlene Marie Ross
Executive Assistant for Education
Division of Human Subject Protections
Office for Protection from Research Risks
National Institutes of Health
9000 Rockville Pike
Building 31, Room 5B59
Bethesda, MD  20892
Telephone:  (301) 496-8101
 
 
**THE MAILING ADDRESS GIVEN FOR SENDING APPLICATIONS TO THE DIVISION OF
RESEARCH GRANTS OR CONTACTING PROGRAM STAFF IN THE WESTWOOD BUILDING IS THE
CENTRAL MAILING ADDRESS FOR THE NATIONAL INSTITUTES OF HEALTH.  APPLICANTS WHO
USE EXPRESS MAIL OR A COURIER SERVICE ARE ADVISED TO FOLLOW THE CARRIER'S
REQUIREMENTS FOR SHOWING A STREET ADDRESS.  THE ADDRESS FOR THE WESTWOOD
BUILDING IS:
 
5333 Westbard Avenue
Bethesda, Maryland 20816
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
            NIH GUIDE - Vol. 20, No. 6, February 8, 1991 - Page 21

